N-myc downstream-regulated gene 2 (NDRG2) is a differentiation- and stress-associated molecule that is predominantly expressed in astrocytes in the central nervous system. In this study, we examined the expression and role of NDRG2 in experimental autoimmune encephalomyelitis (EAE), which is an animal model of multiple sclerosis. Western blot and immunohistochemical analysis revealed that the expression of NDRG2 was observed in astrocytes of spinal cord, and was enhanced after EAE induction. A comparative analysis of wild-type and Ndrg2-/- mice revealed that deletion of Ndrg2 ameliorated the clinical symptoms of EAE. Although Ndrg2 deficiency only slightly affected the inflammatory response, based on the results of flow cytometry, qRT-PCR, and immunohistochemistry, it significantly reduced demyelination in the chronic phase, and, more importantly, neurodegeneration both in the acute and chronic phases. Further studies revealed that the expression of astrocytic glutamate transporters, including glutamate aspartate transporter (GLAST) and glutamate transporter 1, was more maintained in the Ndrg2-/- mice compared with wild-type mice after EAE induction. Consistent with these results, studies using cultured astrocytes revealed that Ndrg2 gene silencing increased the expression of GLAST, while NDRG2 over-expression decreased it without altering the expression of glial fibrillary acidic protein. The effect of NDRG2 on GLAST expression was associated with the activation of Akt, but not with the activation of nuclear factor-kappa B. These findings suggest that NDRG2 plays a key role in the pathology of EAE by modulating glutamate metabolism. Cover Image for this Issue: doi: 10.1111/jnc.14173.
Pubmed ID: 29315585 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD16/32
View all literature mentionsThis polyclonal targets ACTIVE& x00AE; Caspase-3
View all literature mentionsThis polyclonal targets ATF-3 (C-19)
View all literature mentionsThis polyclonal targets Choline Acetyltransferase (ChAT)
View all literature mentionsThis monoclonal targets Mouse Thymus / Spleen The 30-F11 clone has been reported to react with all isoforms and both alloantigens of CD45, which is found on hematopoietic stem cells and all cells of hematopoietic origin, except erythrocytes.
View all literature mentionsThis monoclonal targets Myelin Basic Protein (MBP), aa 129-138
View all literature mentionsThis monoclonal targets Cnp
View all literature mentionsThis monoclonal targets APC
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets NF-KappaB p65, phospho (Ser536)
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets GLAST (ACSA-1)
View all literature mentionsThis polyclonal targets Glutamate Transporter Glial
View all literature mentionsThis monoclonal targets NeuN
View all literature mentionsThis polyclonal targets Rabbit Glial Fibrillary Acidic Protein (GFAP)
View all literature mentionsThis polyclonal targets NDRG2 (E-20)
View all literature mentionsMus musculus with name C57BL/6NCrl from IMSR.
View all literature mentions